Mimedx Group Stock Performance
| MDXG Stock | USD 5.12 0.03 0.59% |
The company secures a Beta (Market Risk) of 0.77, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MiMedx's returns are expected to increase less than the market. However, during the bear market, the loss of holding MiMedx is expected to be smaller as well. At this point, MiMedx Group has a negative expected return of -0.51%. Please make sure to verify MiMedx's jensen alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if MiMedx Group performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days MiMedx Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 82 M | |
| Total Cashflows From Investing Activities | -9.6 M |
MiMedx Relative Risk vs. Return Landscape
If you would invest 710.00 in MiMedx Group on November 15, 2025 and sell it today you would lose (198.00) from holding MiMedx Group or give up 27.89% of portfolio value over 90 days. MiMedx Group is currently does not generate positive expected returns and assumes 2.1859% risk (volatility on return distribution) over the 90 days horizon. In different words, 19% of stocks are less volatile than MiMedx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MiMedx Target Price Odds to finish over Current Price
The tendency of MiMedx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.12 | 90 days | 5.12 | about 91.74 |
Based on a normal probability distribution, the odds of MiMedx to move above the current price in 90 days from now is about 91.74 (This MiMedx Group probability density function shows the probability of MiMedx Stock to fall within a particular range of prices over 90 days) .
MiMedx Price Density |
| Price |
Predictive Modules for MiMedx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MiMedx Group. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MiMedx's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
MiMedx Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MiMedx is not an exception. The market had few large corrections towards the MiMedx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MiMedx Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MiMedx within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.57 | |
β | Beta against Dow Jones | 0.77 | |
σ | Overall volatility | 0.80 | |
Ir | Information ratio | -0.27 |
MiMedx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MiMedx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MiMedx Group can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MiMedx Group generated a negative expected return over the last 90 days | |
| About 72.0% of the company shares are owned by institutional investors |
MiMedx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MiMedx Stock often depends not only on the future outlook of the current and potential MiMedx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MiMedx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 149 M | |
| Cash And Short Term Investments | 104.4 M |
MiMedx Fundamentals Growth
MiMedx Stock prices reflect investors' perceptions of the future prospects and financial health of MiMedx, and MiMedx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MiMedx Stock performance.
| Return On Equity | 0.19 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 647.74 M | ||||
| Shares Outstanding | 148.1 M | ||||
| Price To Earning | 23.73 X | ||||
| Price To Book | 3.23 X | ||||
| Price To Sales | 1.96 X | ||||
| Revenue | 348.88 M | ||||
| EBITDA | 65.35 M | ||||
| Cash And Equivalents | 72.5 M | ||||
| Cash Per Share | 0.64 X | ||||
| Total Debt | 24.84 M | ||||
| Debt To Equity | 0.69 % | ||||
| Book Value Per Share | 1.61 X | ||||
| Cash Flow From Operations | 66.2 M | ||||
| Earnings Per Share | 0.27 X | ||||
| Total Asset | 263.92 M | ||||
| Retained Earnings | (91.26 M) | ||||
| Current Asset | 96.31 M | ||||
| Current Liabilities | 26.78 M | ||||
About MiMedx Performance
By analyzing MiMedx's fundamental ratios, stakeholders can gain valuable insights into MiMedx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MiMedx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MiMedx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. Mimedx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 811 people.Things to note about MiMedx Group performance evaluation
Checking the ongoing alerts about MiMedx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MiMedx Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MiMedx Group generated a negative expected return over the last 90 days | |
| About 72.0% of the company shares are owned by institutional investors |
- Analyzing MiMedx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MiMedx's stock is overvalued or undervalued compared to its peers.
- Examining MiMedx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MiMedx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MiMedx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MiMedx's stock. These opinions can provide insight into MiMedx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |